News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Tower Semiconductor signed $1.3 billion in silicon photonics contracts for 2027 and secured $290 million in prepayments to fund capacity expansion.
  • Wolfspeed shares jumped 20% after a thematic research firm named it an AI-infrastructure standout, extending a multi-day semiconductor rally.
  • Nvidia CEO Jensen Huang joined President Trump on a trip to China, boosting sentiment for AI-infrastructure suppliers.
  • Gilat reported Q1 revenue rose 20% to $110.5 million and delivered GAAP operating income, reaffirming 2026 growth and EBITDA guidance.
  • Vishay posted Q1 revenue of $839.2 million with a strong 1.34 book-to-bill and reaffirmed higher Q2 revenue and margin guidance.
  • Quaest poll shows Lula 42% and Flavio Bolsonaro 41% in a simulated runoff, signaling a tight October presidential race.
  • J.P. Morgan downgraded Heineken to neutral citing leadership uncertainty, flagging potential slowdown in momentum into Q2.

Latest Articles

CoinShares ETPs Now Available on Bourse Direct as France Opens Retail Access to Regulated Crypto Products

CoinShares ETPs Now Available on Bourse Direct as France Opens Retail Access to Regulated Crypto Products

CoinShares plc, a leading global digital asset manager listed on Nasdaq, announced that five of its physically-backed cryptocurrency Exchange-Traded Products (ETPs) are now available to retail investors through Bourse Direct, a major French online brokerage. This listing enables direct investment exposure in crypto assets such as Bitcoin, Ethereum,…

WeShop to Present at the 16th Annual LD Micro Invitational

WeShop to Present at the 16th Annual LD Micro Invitational

WeShop Holdings Limited, a pioneering social commerce platform that integrates community ownership into retail, announced that its founder will present at the 16th Annual LD Micro Invitational. The presentation will detail WeShop's business model, strategic roadmap, and plans for expanding its market presence in the UK and US, emphasizing the platf…

onsemi Reports First Quarter 2026 Results

onsemi Reports First Quarter 2026 Results

onsemi reported Q1 2026 revenue of $1.513 billion, slightly down sequentially but up 5% year-over-year, with non-GAAP operating margin at 19.1%, operating income growing 10% year-over-year—double the pace of revenue growth. The company highlighted more than doubling AI data center revenue and progress in electric vehicle and software-defined vehicl…

James River Announces First Quarter 2026 Results

James River Announces First Quarter 2026 Results

James River Group Holdings, Inc. announced its financial results for Q1 2026, showing a net loss primarily due to $6.7 million in reinsurance reinstatement premiums linked to a major claim. Despite this, the company saw modest growth in its excess and surplus casualty lines and reduced general administrative expenses by 10.5%. Investment income ros…

NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025

NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025

NFT Limited (NYSE American: MI), an online platform for international art and collectibles trading, announced the filing of its 2025 annual report (Form 20-F) with the SEC. The report includes audited financial statements featuring a going concern emphasis paragraph from the independent auditor, signaling uncertainty about the company’s ability to …

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Aktis Oncology initiated a Phase 1b clinical trial for AKY-2519, a B7-H3 targeted miniprotein radioconjugate, evaluating it in metastatic castration-resistant prostate cancer (mCRPC) patients including those naïve and experienced with PLUVICTO®. A parallel Phase 1b basket trial is planned for other B7-H3 expressing tumors such as lung and colorecta…

Devon Energy and Coterra Energy Shareholders Approve Merger

Devon Energy and Coterra Energy Shareholders Approve Merger

Shareholders of Devon Energy Corporation and Coterra Energy Inc. have approved the all-stock merger, expected to close around May 7, 2026. The merger will create a larger company with complementary asset bases, aiming to enhance margins, accelerate free cash flow growth, and increase shareholder returns. Devon shareholders will own about 54% and Co…

Adeia Announces First Quarter 2026 Financial Results

Adeia Announces First Quarter 2026 Financial Results

Adeia Inc. announced robust first quarter 2026 results, with $105 million revenue, $58 million operating cash flow, and a high adjusted EBITDA margin of 60%. The company secured eight license agreements, including new multi-year contracts with AMD and Microsoft, driving diversification beyond Pay-TV into semiconductors, consumer electronics, social…

Gaia Reports First Quarter 2026 Financial Results

Gaia Reports First Quarter 2026 Financial Results

Gaia, Inc. reported a 2% increase in revenue to $24.3 million for Q1 2026 versus the prior year, while gross profit remained flat. The company is strategically shifting focus from third-party subscriber growth to expanding direct membership to improve subscriber value and retention. Despite a modest increase in net loss to $1.3 million, Gaia contin…

EverQuote Announces First Quarter 2026 Financial Results

EverQuote Announces First Quarter 2026 Financial Results

EverQuote, Inc. announced its first quarter 2026 results showing 15% year-over-year revenue growth to $190.9 million, net income of $18.7 million, and a 30% increase in adjusted EBITDA to a record $29.3 million. The company exceeded guidance across all financial metrics and projects continued growth in Q2, driven by AI-powered solutions and expansi…

AH Realty Trust Reports First Quarter 2026 Results

AH Realty Trust Reports First Quarter 2026 Results

AH Realty Trust reported its first quarter 2026 financial results, announcing a GAAP net loss of $0.33 per diluted share but achieving increased Funds From Operations (FFO), As Adjusted to $0.15 per diluted share. The company implemented a major business restructuring focused on exiting the multifamily sector, divesting construction and financing b…

Silvaco Announces Participation at Upcoming Investor Conferences

Silvaco Announces Participation at Upcoming Investor Conferences

Silvaco Group, Inc., a provider of AI-enabled TCAD, EDA software, and SIP solutions for semiconductor design, announced that its CEO, Walden Rhines, and CFO, Chris Zegeralli, will participate in the Needham Technology, Media, and Consumer Conference and the B. Riley Securities 2026 Investor Conference. The company will offer live webcasts of these …

Kyntra Bio to Report First Quarter 2026 Financial Results

Kyntra Bio to Report First Quarter 2026 Financial Results

Kyntra Bio, a biopharmaceutical company focused on oncology and rare diseases, will report its first quarter 2026 financial results on May 11, 2026, followed by a conference call with investors. The company is advancing multiple drug candidates including Roxadustat, approved in several countries for anemia related to chronic kidney disease, and FG-…

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Capricor Therapeutics, a biotech firm specializing in cell and exosome-based therapies for rare diseases, will release its Q1 2026 financial results on May 12, 2026, followed by a conference call and webcast. The company highlighted its lead candidate, Deramiocel, targeting Duchenne muscular dystrophy, and discussed its proprietary StealthX platfor…

ThredUp Announces First Quarter 2026 Results

ThredUp Announces First Quarter 2026 Results

ThredUp Inc. reported a 15% YoY revenue increase to $81.7 million in Q1 2026, with record active buyers growing 25% to 1.71 million. The company improved gross margin slightly to 79.2% and adjusted EBITDA margin to 3.4%. Despite a net loss, ThredUp raised its full-year 2026 revenue, gross margin, and adjusted EBITDA margin guidance, signaling confi…

Cytokinetics Executive Executes Stock Option Exercise and Subsequent Sale

Cytokinetics Executive Executes Stock Option Exercise and Subsequent Sale

Andrew Callos, the Executive Vice President and Chief Commercial Officer at Cytokinetics Inc (NASDAQ: CYTK), completed a series of transactions involving company stock on May 1, 2026. The activity included the exercise of non-qualified stock options followed by a sale of common shares totaling $1,030,705. This transaction occurred while the company…